Analysts expect Vor Biopharma Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.93 M | 7.62 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.12 M | 6.26 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.53 M | 6.94 M |
Analysts expect Vor Biopharma Inc. to report earnings per share of -0.79 for Q3 26, against a range of -0.82 to -0.76. The most recent reported quarter, Q2 26, came in at -1.16, a 70.6% miss against the -0.68 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -8.00 | -8.80 | -5.20 | -251.22 | -121.63 | 44.50 | -5.11 | -1.16 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -8.01 | -5.50 | -4.98 | -8.78 | -3.05 | 15.75 | -0.70 | -0.61 | -0.76 | -0.76 | -0.97 | -0.94 | 26.77 | 33.76 | -17.25 | -26.61 | ||||||||||
| Low Estimate | -8.61 | -6.52 | -5.84 | -9.90 | -3.53 | 14.19 | -0.80 | -0.75 | -0.82 | -0.86 | -1.03 | -1.02 | 23.53 | 30.70 | -20.63 | -32.39 | ||||||||||
| Consensus Estimate | -8.31 | -6.01 | -5.41 | -9.34 | -3.29 | 14.97 | -0.75 | -0.68 | -0.79 | -0.81 | -1.00 | -0.98 | 25.15 | 32.23 | -18.94 | -29.50 |
Pull Wall Street consensus for Vor Biopharma Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VOR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VOR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VOR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();